April 25, 2024

• 

[THE INVESTOR] As of Nov. 6 12:55 P.M., Kwangdong Pharmaceutical slightly edged up 0.85% to 8,290 won. It had increased 3.37% through the past month. Standard deviation, which indicates variableness, records 1% over the same period of time over one month.

Compared with its close competitors within the same industry, KOSPI, as the monthly volatility was the lowest, the earnings rate of Kwangdong Pharmaceutical over one month was comparatively low. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was 3.3. Though the volatility was the lowest, the return-on-risk recorded a poor value because the return was not so high. However, compared with the KOSPI industry, the return-on-risk is below the industrial mean, 11.5, and thus it is hard to say that the industrial comparison performance was positive.


By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.